The study was designed to detect differences in the nuclear morphology of tumours and tumour cell populations with different p53 expression in correlation with DNA ploidy and proliferation rate. The paraffin sections from routinely processed samples of 88 breast cancers were immunostained with the monoclonal p53‐antibody DO‐1. After localization and evaluation with a scoring system the sections were destained and stained by the Feulgen method. The nuclei were relocated automatically and measured by means of the image cytometry workstation. Significant differences between the tumours and tumour cell populations with different p53 expression were found in the euploid tumours as well as in the aneuploid tumours and in the breast cancers with a...
Copyright © 2014 Zorka Milićevic ́ et al.This is an open access article distributed under the Creat...
The diagnostic values of the ploidy level, the proliferative activity, and the nuclear size in a ser...
Patients with aggressive breast cancers benefit from chemotherapy prior to surgery. If the biology o...
The study was aimed to detect differences in nuclear morphology between nuclear populations as well ...
The aim of the study was to correlate the DNA Index (DI) and S‐phase fraction (SPF) values determine...
Breast cancer cells can be obtained derectly from the patient with minimal damage by fine-needle sam...
DNA content, proliferative activity (Ki-67 immuno-staining and S-phase fraction by flow cytometry), ...
In breast carcinoma, disruption of the p53 pathway is one of the most common genetic alterations. Th...
Immunohistochemical analysis of the p53 gene protein and cytometric assessment of nuclear DNA were p...
225-230The object of the present study is to detect the ·p53 tumour suppressor gene and proliferati...
We studied the influence of five cell nucleus populations taken as diploid standards with respect to...
One hundred and eighty-eight infiltrating ductal carcinomas of the breast were examined immunohistoc...
Biological variables linked to genomic instability were examined and related to survival in 52 patie...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The chromatin pattern in nuclei from breast ductal proliferative lesions was quantitatively evaluate...
Copyright © 2014 Zorka Milićevic ́ et al.This is an open access article distributed under the Creat...
The diagnostic values of the ploidy level, the proliferative activity, and the nuclear size in a ser...
Patients with aggressive breast cancers benefit from chemotherapy prior to surgery. If the biology o...
The study was aimed to detect differences in nuclear morphology between nuclear populations as well ...
The aim of the study was to correlate the DNA Index (DI) and S‐phase fraction (SPF) values determine...
Breast cancer cells can be obtained derectly from the patient with minimal damage by fine-needle sam...
DNA content, proliferative activity (Ki-67 immuno-staining and S-phase fraction by flow cytometry), ...
In breast carcinoma, disruption of the p53 pathway is one of the most common genetic alterations. Th...
Immunohistochemical analysis of the p53 gene protein and cytometric assessment of nuclear DNA were p...
225-230The object of the present study is to detect the ·p53 tumour suppressor gene and proliferati...
We studied the influence of five cell nucleus populations taken as diploid standards with respect to...
One hundred and eighty-eight infiltrating ductal carcinomas of the breast were examined immunohistoc...
Biological variables linked to genomic instability were examined and related to survival in 52 patie...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
The chromatin pattern in nuclei from breast ductal proliferative lesions was quantitatively evaluate...
Copyright © 2014 Zorka Milićevic ́ et al.This is an open access article distributed under the Creat...
The diagnostic values of the ploidy level, the proliferative activity, and the nuclear size in a ser...
Patients with aggressive breast cancers benefit from chemotherapy prior to surgery. If the biology o...